Sumitomo Pharmaceuticals CO. Ltd.

City:

Osaka

Country:

Japan

Published Applications:

Last publication date:

2006-06-27

Patent Grants:

Last grant date:

2006-06-27

Top Inventors for applications by Sumitomo Pharmaceuticals CO. Ltd.

These are the the leading inventors for applications assigned to Sumitomo Pharmaceuticals CO. Ltd.:

Makoto Kitoh 1 Osaka-shi, Japan
Yasuyuki Ueki 1 Sanda, Japan
Ikue Kudo 1 Osaka, Japan
Mutsuo Taiji 1 Takatsuki-shi, Osaka-fu, Japan

Masami Muraoka 1 Suita, Japan
Michiko Kishino 1 Suita-shi, Osaka-fu, Japan
Michitoshi Sekine 1 Osaka, Japan
Jun Nagamine 1 Osaka-shi, Osaka-fu, Japan

Hitoshi Ban 1 Nishinomiya, Japan
Satoshi Ohnuma 1 Nishinomiya, Japan
Willian Ewan Hume 1 Nishinomiya-shi, Japan
Eiji Sugaru 1 Osaka-shi, Japan

Tsutomu Nakagawa 1 Nagaokakyo-shi, Kyoto-fu, Japan
Naoki Yamazaki 1 Osaka, Japan
Teruhisa Tokunaga 1 Osaka-fu, Japan
Ryu Nagata 1 Nishinomiya-shi, Hyogo-ken, Japan

Yoshifumi INOUE 1 Osaka, Japan
Tomokazu Nagano 1 Osaka, Japan
Junji Ichihara 1 Ibaraki-shi, Japan
Masakazu Isobe 1 Osaka, Japan

Mutsuo Taiji 1 Takatsuki-shi, Japan
Yoshiaki Isobe 1 Osaka, Japan
Masanori Tobe 1 Osaka, Japan
Kazuhiko Okazaki 1 Nishinomiya, Japan

Recent patent applications by Sumitomo Pharmaceuticals CO. Ltd.

Sumitomo Pharmaceuticals CO. Ltd. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2006-06-27 ✅ Patent 7,067,528 granted on 2006-06-27

US10474725

1, 2-dihydro-2-oxo-1, 8-naphthyridine derivative

#2 | 2006-05-04

US20060094737A1

Chemistry; metallurgy

Novel uracil derivatives and medicinal use thereof

#3 | 2005-10-13

US20050227978A1

Chemistry; metallurgy

Fibrosis inhibitor

#4 | 2005-09-06 ✅ Patent 6,939,887 granted on 2005-09-06

US10470813

Benzimidazolidinone derivatives

#5 | 2005-06-02

US20050119174A1

Physics

Novel blood sugar controller and method of screening the same

#6 | 2005-03-22 ✅ Patent 6,869,609 granted on 2005-03-22

US9555629

Method for treatment of renal failure and occlusive lesion of blood vessels by administration of hepatocyte growth factor

AssigneeID:

291620 ⎘